Growth inhibition of Candida albicans by vaginal cells from naive mice

Medical Mycology

Volumn 37, Issue 4, 1999, Pages 251-259

  Steele, C ^a   Ozenci, H ^a   Luo, W ^a   Scott, M ^a   Fidel Jr , Paul L ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Candida albicans; Epithelial cells; Vaginal mucosa; Vaginitis

Indexed keywords

ANIMAL CELL; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CELL KILLING; CONTROLLED STUDY; FEMALE; FUNGUS GROWTH; GROWTH INHIBITION; INFECTION RESISTANCE; MOUSE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NEUTROPHIL; NONHUMAN; SPLEEN CELL; VAGINA CANDIDIASIS; VAGINA EPITHELIUM; VAGINA MUCOSA;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS, VULVOVAGINAL; CELL DIVISION; CELL LINE; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; EPITHELIOID CELLS; FEMALE; HELA CELLS; HUMANS; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; MICE; MICE, INBRED CBA; SPLEEN; TUMOR CELLS, CULTURED; VAGINA;

ANIMALIA; CANDIDA ALBICANS; FUNGI; MURINAE;

EID: 0032838321     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-280X.1999.00228.x     Document Type: Article

References (46)

1. Sobel JD. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann N Y Acad Sci 1988; 544: 547-557.
2. Odds FC. Chronic mucocutaneous candidiosis. In: Candida and candidosis. Baltimore, MD: University Park Press, 1988; 104-110.
3. Romani L, Mencacci A, Cenci E, et al. CD+ subset expression in murine candidiasis. J Immunol 1993; 150: 925-931.
4. Kirkpatrick CH. Chronic mucocutaneous candidiasis. Eur J Clin Microbiol Infect Dis 1989; 8: 448-456.
5. Cenci E, Mencacci A, Spaccapelo R, et al. T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J Infect Dis 1995; 171: 1279-1288.
6. Witkin SS. Inhibition of Candida-induced lymphocyte proliferation by antibody to Candida albicans. Obstet Gynecol 1986; 68: 696-699.
7. Witkin SS, Hirsch J, Ledger WJ. A macrophage defect in women with recurrent Candida vaginitis and its reversal in vitro by prostaglandin inhibitors. Am J Obstet Gynecol 1986; 155: 790-795.
8. Hobbs JR, Briden D, Davidson F, Kahan M, Oates JK. Immunological aspects of candidal vaginitis. Proc R Soc Med 1977; 70: 11-14.
9. Syverson RA, Buckley H, Gibian J, Ryan JJM. Cellular and humoral immune status in women with chronic Candida vaginitis. Am J Obstet Gynecol 1979; 134: 624-627.
10. Fidel Jr PL, Lynch ME, Redondo-Lopez V, Sobel JD, Robinson R. Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis (RVVC). J Infect Dis 1993; 168: 1458-1465.
11. Mendling W, Koldovsky U. Investigations by cell-mediated immunologic tests and therapeutic trials with thymopentin in vaginal mycoses. Infect Dis Obstet Gynecol 1996; 4: 225-231.
12. Fong IW, McCleary P, Read S. Cellular immunity of patients with recurrent or refractory vulvovaginal moniliasis. Am J Obstet Gynecol 1992; 166: 887-890.
13. Fidel Jr PL, Lynch ME, Sobel JD. Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis. Infect Immun 1993; 61: 4202-4207.
14. Fidel Jr PL, Lynch ME, Sobel JD. Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis. Infect Immun 1994; 62: 1032-1038.
15. Fidel Jr PL, Lynch ME, Conaway DH, Tait L, Sobel JD. Mice immunized by primary vaginal C. albicans infection develop acquired vaginal mucosal immunity. Infect Immun 1995; 63: 547-553.
16. Fidel Jr PL, Lynch ME, Sobel JD. Circulating CD4 and CD8 T cells have little impact on host defence against experimental vaginal candidiasis. Infect Immun 1995; 63: 2403-2408.
17. Brummer E, McEwen JG, Stevens DA. Fungicidal activity of murine inflammatory polymorphonuclear neutrophils: comparison with murine peripheral blood PMN. Clin Exp Immunol 1986; 66: 681-690.
18. Morrison CJ, Brummer E, Stevens DA. Effect of a local immune reaction on peripheral blood polymorphonuclear neutrophil microbicidal function:studies with fungal targets. Cell Immunol 1987; 110: 176-182.
19. Qian Q, Jutila MA, Rooijen NV, Cutler JE. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J Immunol 1994; 152: 5000-5008.
20. Beno DWA, Stover AG, Mathews HL. Growth inhibition of Candida albicans hyphae by CD8+ lymphocytes. J Immunol 1995; 154: 5273-5281.
21. Baccarini M, Bistoni F, Puccetti P, Garaci E. Natural cell-mediated cytotoxicity against Candida albicans induced by cyclophosphamide:nature of the in vitro cytotoxic effector. Infect Immun 1983; 42: 1-9.
22. Beno DWA, Mathews HL. Growth inhibition of Candida albicans by interleukin-2-induced lymph node cells. Cell Immunol 1990; 128: 89-100.
23. Fratti RA, Ghannoum MA, Edwards Jr JE, Filler SG. Gamma interferon protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis. Infect Immun 1996; 64: 4714-4718.
24. Hedges SR, Agace WW, Svanborg C. Epithelial cytokine responses and mucosal cytokine networks. Trends Microbiol 1995; 3: 266-270.
25. Fidel Jr PL, Wolf NA, KuKuruga MA. T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery. Infect Immun 1996; 64: 3793-3799.
26. Julius MH, Simpson E, Herzenberg A. A rapid method for the isolation of functional thymus-derived lymphocytes. Eur J Immunol 1973; 3: 645-649.
27. Champlin AK, Dorr DL, Gates AH. Determining the stage of the estrous cycle in the mouse by the appearance of the vagina. Biol Reprod 1974; 8: 491-494.
28. Djeu JY, Parapanissios A, Halkias D, Friedman H. A rapid 3H-glucose incorporation assay for determination of lymphoid cell-mediated inhibition of Candida albicans growth. J Immunol Methods 1986; 92: 73-77.
29. Forsyth CB, Mathews HL. Lymphocytes utilize CD11b/CD18 for adhesion to Candida albicans. Cell Immunol 1996; 170: 91-100.
30. Carr DJJ, Mayo S, Woolley TW, Decostas BR. Immunregulatory properties of (+)-pentazocine and sigma ligands. Immunology 1992; 77: 527-531.
31. Vecchiarelle A, Bistoni F, Cenci E, Perito S, Cassone A. In-vitro killing of Candida species by murine immunoeffectors and its relationship to the experimental pathogenicity. J Med Vet Mycol 1985; 23: 377-387.
32. Baccarini M, Vecchiarelle A, Cassone A, Bistoni F. Killing of yeast, germ-tube and mycelial forms of Candida albicans by murine effectors as measured by a radiolabel release microassay. J Gen Microbiol 1985; 131: 505-513.
33. Brummer E, Sugar AM, Stevens DA. Immunological activation of polymorphonuclear neutrophils for fungal killing:studies with murine cells and Blastomyces dermatitidis in vitro. J Leukoc Biol 1984; 36: 505-520.
34. Parr MB, Parr EL. Langerhans cells and T lymphocyte subsets in the murine vagina and cervix. Biol Reprod 1991; 44: 491-498.
35. Nandi D, Allison JP. Characterization of neutrophils and T lymphocytes associated with the murine vaginal epithelium. Reg Immunol 1994; 5: 332-338.
36. Childs WC, Gibbons RJ. Use of percoll density gradient for studying the attachment of bacteria to oral epithelial cells. J Dent Res 1988; 67: 826-830.
37. Sobel JD, Myer PG, Kaye D, Levinson ME. Candida albicans adherence to vaginal epithelial cells. J Infect Dis 1981; 143: 76-82.
38. Trumbore DJ, Sobel JD. Recurrent vulvovaginal candidiasis: vaginal epithelial cell susceptibility to Candida albicans adherence. Obstet Gynecol 1986; 67: 810-814.
39. Wira CR, Rossoll RM. Antigen-presenting cells in the female reproductive tract: influence of sex hormones on antigen presentation in the vagina. Immunology 1995; 84: 505-508.
40. Hoyne GF, Callow MG, Kuo MC, Thomas WR. Presentation of peptides and proteins by intestinal epithelial cells. Immunology 1993; 80: 204-208.
41. Bland PW, Warren LG. Antigen presentation by epithelial cells of the rat small intestine. Immunology 1986; 58: 1-7.
42. Yamamoto M, Fujihashi K, Kawabata K, McGhee JR, Kiyono H. A mucosal intranet: intestinal epithelial cells downregulate intraepithelial, but not peripheral, T lymphocytes. J Immunol 1998; 160: 2188-2196.
43. Cantorna MT, Balish C. Acquired immunity to systemic candidiasis in immunodeficient mice. J Infect Dis 1991; 164: 936-943.
44. Cantorna MT, Mook D, Balish E. Resistance of congenitally immunodeficient gnotobiotic mice to vaginal candidasis. Infect Immun 1990; 58: 3813-3815.
45. Styrt B, Sugarman B. Estrogens and infection. Rev Infect Dis 1991; 13: 1139-1150.
46. Carlsten H, Holmdahl R, Tarkowski A. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB × NZW) F1 mice. Immunology 1991; 73: 186-190.